ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014